1 |
Adams LM, Warburton MJ, Hayman AR (2006). Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP). Cell Biol Int, 31,191-5.
|
2 |
Agarwal C, Singh RP, Dhanalakshmi S, et al (2003). Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene, 22, 8271-82.
DOI
|
3 |
Ahmad A (2013). Pathways to Breast Cancer Recurrence. ISRN Oncol, 2013, 1-16.
|
4 |
Asad SF, Singh S, Ahmad A, Hadi SM (1998). Flavonoids: Antioxidants in diet and potential anticancer agents. Med Sci Res, 26, 723-28.
|
5 |
Deep G, Agarwal R (2007). Chemopreventive efficacy of silymarin in skin and prostate cancer. Integr Cancer Ther 6, 130-45.
DOI
|
6 |
Duan WJ, Li QS., Xia MY, et al (2011). Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways. Biol Pharm Bull, 34, 47-53.
DOI
|
7 |
Kaina B (2003). DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem Pharmacol, 66, 1547-54.
DOI
|
8 |
Li L, GaoY , Zhang L, et al (2008). Silibinin inhibits cell growth and induces apoptosis by caspase activation, down-regulating survivin and blocking EGFR-ERK activation in renal cell carcinoma. Cancer Lett, 272, 61-9.
DOI
|
9 |
Lu Y, Lin YZ, LaPushin R, et al (1999). The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene, 18, 7034-45.
DOI
|
10 |
Li LQ, Li XL, Wang L, et al (2012). Matrine inhibits breast cancer growth via miR-21/PTEN/Akt pathway in MCF-7 cells. Cell Physiol Biochem, 30, 631-41.
DOI
|
11 |
Mokhtari MJ, Motamed N, Shokrgozar M (2008). Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line. Cell Biol Int, 32, 888-92.
DOI
|
12 |
Roy S, Kaur M, Agarwal C, et al (2007). p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol Cancer Ther, 6, 2696-707.
DOI
|
13 |
Sharma G, Singh RP, Chan DC, Agarwal R (2003). Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells. Anticancer Res, 23, 2649-55.
|
14 |
Tiwari P, Kumar A, Balakrishnan S, Kushwaha HS, Mishra KP (2011). Silibinin-induced apoptosis in MCF7 and T47D human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest, 29, 12-20.
DOI
|
15 |
Zi X, Feyes DK, Agarwal R (1998). Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins. Clin Cancer Res, 4, 1055-64.
|
16 |
Vojtesek B, Lane DP (1993). Regulation of p53 protein expression in human breast cancer cell lines. J Cell Sci, 105, 607-12.
|
17 |
Wang HJ, Wei XF, Jiang YY, et al (2010). Silibinin induces the generation of nitric oxide in human breast cancer MCF-7 cells. Free Radic Res, 44, 577-84.
DOI
|
18 |
Weng LP, Brown JL, Eng C (2001). PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet, 15, 599-604.
|
19 |
Zi X, Agarwal R (1999). Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention. Proc Natl Acad Sci USA, 96, 7490-95.
DOI
|